The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Adaptive design of VALOR, a phase III trial of vosaroxin or placebo in combination with cytarabine for patients with first relapsed or refractory acute myeloid leukemia.
C. R. Mehta
Consultant or Advisory Role - Sunesis Pharmaceuticals
G. Michelson
Employment or Leadership Position - Sunesis Pharmaceuticals
Stock Ownership - Sunesis Pharmaceuticals
M. Salganik
Consultant or Advisory Role - Sunesis Pharmaceuticals
J. Feaster
Consultant or Advisory Role - Sunesis Pharmaceuticals
R. Allen
Employment or Leadership Position - Sunesis Pharmaceuticals
Stock Ownership - Sunesis Pharmaceuticals
A. L. Cahill
Consultant or Advisory Role - Sunesis Pharmaceuticals
J. A. Fox
Employment or Leadership Position - Sunesis Pharmaceuticals
Stock Ownership - Sunesis Pharmaceuticals
S. B. Ketchum
Employment or Leadership Position - Sunesis Pharmaceuticals
Stock Ownership - Sunesis Pharmaceuticals
F. Ravandi
Consultant or Advisory Role - Sunesis Pharmaceuticals
Honoraria - Sunesis Pharmaceuticals
Research Funding - Sunesis Pharmaceuticals
H. P. Erba
Consultant or Advisory Role - Sunesis Pharmaceuticals
Research Funding - Sunesis Pharmaceuticals
G. J. Schiller
Consultant or Advisory Role - Sunesis Pharmaceuticals
Research Funding - Sunesis Pharmaceuticals
R. K. Stuart
Consultant or Advisory Role - Sunesis Pharmaceuticals
Research Funding - Sunesis Pharmaceuticals
Expert Testimony - Sunesis Pharmaceuticals
N. Vey
Honoraria - Sunesis Pharmaceuticals
E. J. Feldman
Consultant or Advisory Role - Sunesis Pharmaceuticals